Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
NUP98 fusion oncoproteins (FOs) are a hallmark of childhood acute myeloid leukemia (AML). NUP98 FOs drive leukemogenesis through phase-separated condensate formation and maintenance of an active chromatin landscape at stem cell-associated genes in cooperation with epigenetic regulators. Here we show that MYST family histone acetyltransferase (HAT) complex proteins including KAT6A/MOZ, KAT7/HBO1, and the common KAT6A/7 complex subunit BRPF1 associate with NUP98 FOs on chromatin and within condensates. MYST HATs are molecular dependencies in NUP98-rearranged (NUP98-r) leukemia, and genetic inactivation or pharmacologic inhibition of Kat6a and Kat7 impairs NUP98-r cell fitness. KAT6A/7 inhibition decreased global H3K23ac levels, displaced NUP98::HOXA9 from chromatin at the Meis1 locus, and led to myeloid cell differentiation. Additionally, KAT6A/7 inhibition decreased leukemic burden in multiple NUP98-r leukemia xenograft mouse models, synergized with Menin inhibitor treatment, and was efficacious in Menin inhibitor-resistant cells. In summary, we show that MYST family HATs are therapeutically actionable dependencies in NUP98-r AML.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1158/2159-8290.CD-24-1772 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
KAT6A and KAT7 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in NUP98-Rearranged Acute Myeloid Leukemia.
Cancer Discov
June 2025
St. Jude Children's Research Hospital, Memphis, TN, United States.
NUP98 fusion oncoproteins (FOs) are a hallmark of childhood acute myeloid leukemia (AML). NUP98 FOs drive leukemogenesis through phase-separated condensate formation and maintenance of an active chromatin landscape at stem cell-associated genes in cooperation with epigenetic regulators. Here we show that MYST family histone acetyltransferase (HAT) complex proteins including KAT6A/MOZ, KAT7/HBO1, and the common KAT6A/7 complex subunit BRPF1 associate with NUP98 FOs on chromatin and within condensates.
View Article and Find Full Text PDFCatalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemia.
Cancer Discov
June 2025
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Targeting the MYST acetyltransferases are an exciting therapeutic opportunity in acute myeloid leukaemia (AML). Here we define the individual and combined contribution of KAT6A, KAT6B and KAT7, in range of AML models showing that although KAT6A/B inhibition is efficacious in some pre-clinical models, simultaneous targeting of KAT7, with the novel inhibitor PF-9363, markedly increases efficacy. KAT7 interacts with Menin and the MLL complex and is co-localised at chromatin to co-regulate oncogenic transcriptional programs.
View Article and Find Full Text PDFSPT6 regulates H3K14Ac deposition in mouse embryonic stem cells.
Cell Rep
June 2025
Longevity and Aging Institute, The Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200030, China. Electronic address:
SPT6 (suppressor of Ty 6) is a conserved histone chaperone that plays critical roles in RNA Pol II progression and nucleosome reassembly. However, the functions of SPT6 in chromatin regulation remain incompletely understood. Here, we show that SPT6 localizes to histone H3 lysine 14 acetylation (H3K14Ac)-enriched regions in mouse embryonic stem cells (mESCs).
View Article and Find Full Text PDFUnderstanding the molecular pathogenesis of MLL fusion oncoprotein (MLL-FP) leukaemia has spawned epigenetic therapies that have improved clinical outcomes in this often-incurable disease. Using genetic and pharmacological approaches, we define the individual and combined contribution of KAT6A, KAT6B and KAT7, in MLL-FP leukaemia. Whilst inhibition of KAT6A/B is efficacious in some pre-clinical models, simultaneous targeting of KAT7, with the novel inhibitor PF-9363, increases the therapeutic efficacy.
View Article and Find Full Text PDFING4 and ING5 are essential for histone H3 lysine 14 acetylation and epicardial cell lineage development.
Development
March 2024
Walter and Eliza Hall Institute of Medical Research, Epigenetics and Development Division, Melbourne, VIC 3052, Australia.
Article Synopsis
- ING4 and ING5 are proteins that help regulate gene expression and are part of histone acetyltransferase complexes involved in heart development.
- Mutations in genes like KAT6A and KAT6B are linked to heart defects, and studies on mice with disrupted ING4 and ING5 reveal serious developmental issues, including heart defects.
- The absence of these proteins leads to problems with cell development, structure, and gene expression during early embryonic stages, suggesting mutations in ING5 may contribute to human heart conditions like ventricular septal defects.*